Company research / ESMC

Escalon Medical Corp (ESMC)

SEC name ESCALON MEDICAL CORP · CIK 0000862668 · OTC · Electromedical & Electrotherapeutic Apparatus

  • Sector Manufacturing
  • Incorporated PA
  • Fiscal year ends Jun 30

For the year ended 2026-06-30, Escalon Medical Corp reported revenue of $12.74M. Revenue grew 5.7% from the prior annual period.

Key ratios (year ended 2026-06-30)

43.7%
Gross margin (computed)
0.4%
Operating margin
31.5%
Net margin
67.7%
Return on year-end equity
5.7%
Revenue growth (YoY)

Computed by TickerFacts from revenue minus cost of revenue. This may differ from the issuer's reported gross profit or margin; check the revenue and cost definitions.

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 10-K (annual report) · 2026-10-13

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

Period ended2026-06-302025-06-302024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-30
Revenue$12.74M$12.05M$11.98M$12.18M$10.70M$10.47M$9.40M$9.63M$11.40M$11.23M
Cost of Revenue$7.17M$6.54M$6.84M$6.70M$6.10M$6.04M$5.20M$5.00M$6.30M$6.08M
Gross Profit (computed)$5.57M$5.51M$5.15M$5.48M$4.61M$4.43M$4.20M$4.63M$5.10M$5.15M
R&D Expense$501.5K$753.1K$688.2K$818.8K$991.0K$890.5K$1.12M$739.8K$500.3K$1.05M
Operating Income$45.2K$133.2K-$104.5K$478.5K-$470.1K-$33.7K-$1.40M-$253.0K$204.7K-$626.9K
Depreciation & Amortization$22.6K$37.8K$46.0K$45.2K$48.4K$44.8K$50.1K$50.1K$49.2K$45.9K
EBITDA$67.8K$171.0K-$58.5K$523.7K-$421.6K$11.1K-$1.35M-$202.8K$253.9K-$581.0K
Net Income$4.01M$105.5K-$125.3K$456.8K$18.1K-$52.0K-$650.3K-$250.0K$583.7K-$726.9K
EPS (Diluted)$0.27$0.00-$0.02$0.03$0.00-$0.01-$0.09-$0.04$0.06-$0.10
Total Assets$9.13M$4.99M$4.76M$5.31M$5.17M$5.68M$5.72M$5.13M$5.43M$4.98M
Total Liabilities$3.20M$3.08M$2.95M$3.37M$3.69M$4.22M$4.21M$2.97M$3.01M$3.80M
Shareholders' Equity$5.93M$1.92M$1.81M$1.93M$1.48M$1.46M$1.51M$2.16M$2.41M$1.18M
Cash & Equivalents$3.07M$545.8K$209.0K$889.7K$593.9K$1.65M$826.0K$409.7K$874.0K$544.1K
Operating Cash Flow-$402.6K$380.7K-$602.8K$325.1K-$1.05M$838.7K-$168.5K-$472.7Kn/an/a
Capital Expenditures$4.4K$3.9K$40.3K$6.7K$0$9.4K$59.8K$22.1K$29.4K$0
Free Cash Flow-$407.0K$376.8K-$643.1K$318.5K-$1.05M$829.3K-$228.2K-$494.8Kn/an/a
Shares Outstanding7.42M7.42M7.42M7.42M7.42M7.42M7.42M7.42M7.42M7.53M
Weighted Average Diluted Shares14.60M14.25M7.42M13.56M13.22M7.42M7.42M7.42M9.14M7.55M
EPS (Basic)$0.27$0.00-$0.02$0.03$0.00-$0.01-$0.09-$0.04$0.07-$0.10